RxDoctor Payments Data

Victor Trevino, MD

Family Medicine · Laredo, TXNPI 1982662029

Payments from drug & device makers

$3,760in general payments, 2019–2025

Across 25 payments — averaging $150.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Baxter Healthcare$2K
  • Welch Allyn$1K
  • AbbVie$208
  • Livanova USA, Inc.$163
  • Tris Pharma Inc$160
  • Lemaitre Vascular, Inc.$51
  • plus $45 from 2 others

What the payments were for

  • Food & beverage$62717%
  • Other$3,13383%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,760 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$1,386,499
Medicare patients
179
Services billed
3,344

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide70$63,444
EliquisApixaban109$48,885
TrulicityDulaglutide20$33,926
MounjaroTirzepatide23$21,505
JanuviaSitagliptin Phosphate22$20,075
VraylarCariprazine Hcl15$18,521
XareltoRivaroxaban20$16,062
JanumetSitagliptin Phos/Metformin Hcl30$15,408
MyrbetriqMirabegron26$15,210
JardianceEmpagliflozin26$14,985
Janumet XrSitagliptin Phos/Metformin Hcl11$8,462
EntrestoSacubitril/Valsartan24$8,280
Celecoxib130$7,404
NuedextaDextromethorphan Hbr/Quinidine21$6,250
ErtapenemErtapenem Sodium14$5,290

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$24$55,43143 claims
PfizerEliquis$21$48,885109 claims
AbbVieVraylar$208$18,52115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Laredo

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →